Medmain Speaks

~Official Blog~

Our CEO was selected for the Forbes 30 Under 30 Asia!!

Our CEO Osamu Iizuka was selected for the Forbes 30 Under 30 - Asia’s Healthcare & Science category as announced by Forbes on April 2(JST) . 【About Forbes 30 Under 30 Asia】Forbes selects young entrepreneurs, leaders and changemakers who are under the age of 30 in their respective fields in 23 countries and regions across

Medmain Inc. launches “PidPort”, A Digital Pathology Platform

Medmain Inc. a Japanese health tech startup has launched its service “PidPort, a platform service for pathological image diagnosis, which includes Deep Learning driven pathological analysis.

We received the 2nd Japan Open Innovation Prize

Medmain Inc. and Kyushu Daigaku Kigyobu (a startup activity club of Kyushu University) were together awarded the Minister of Education, Culture, Sports, Science and Technology’s award of the 2nd ” Japan Open Innovation Prize “.

Participated in TechCrunch Disrupt San Francisco 2019

What an amazing week we had at TechCrunch’s Disrupt SF! We’re beyond grateful to have had this opportunity to meet, network, learn, and get inspired the past three days. Thank you again to everyone who stopped by our booth!

AI Major Students Visited our Headquarters!

We had an international group of university students from overseas, as well as Softbank and DEEPCORE visit us at our headquarters the other day!